Medication risk-taking behavior in functional dyspepsia patients

Clinical and Translational Gastroenterology

Volumn 6, Issue 1, 2015, Pages

  Lacy, Brian E ^a   Yu, Jerry ^a   Crowell, Michael D ^b  

^a DARTMOUTH HITCHCOCK MEDICAL CENTER   (United States)

^b MAYO CLINIC   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

HERBACEOUS AGENT; HISTAMINE H2 RECEPTOR ANTAGONIST; PREGABALIN; PROKINETIC AGENT; SEROTONIN UPTAKE INHIBITOR; TRICYCLIC ANTIDEPRESSANT AGENT; VITAMIN;

ABDOMINAL DISCOMFORT; ADULT; ANXIETY; ARTICLE; ATTITUDE TO HEALTH; BLOATING; DEPRESSION; DISEASE DURATION; DISEASE SEVERITY; DRUG USE; DYSPEPSIA; FEMALE; HIGH RISK BEHAVIOR; HUMAN; IMPULSIVENESS; MAJOR CLINICAL STUDY; MALE; PATIENT ATTITUDE; PRESCRIPTION; PRIORITY JOURNAL; PROSPECTIVE STUDY; QUALITY OF LIFE; SELF MEDICATION; SEX DIFFERENCE; SUDDEN DEATH; TREATMENT OUTCOME; UPPER ABDOMINAL PAIN;

EID: 84927651995     PISSN: None     EISSN: 2155384X     Source Type: Journal    
DOI: 10.1038/ctg.2014.18     Document Type: Article

References (23)

1. Tack J, Talley NJ, Camilleri M et al. Functional gastroduodenal disorders. Gastroenterology 2006; 130: 1466-1479.
2. Choung RS, Locke GR, Schleck CD et al. Do distinct dyspepsia subgroups exist in the community? A population-based study. Am J Gastroenterol 2007; 102: 1983-1989.
3. Bisschops R, Karamanolis G, Arts J et al. Relationship between symptoms and ingestion of a meal in functional dyspepsia. Gut 2008; 57: 1495-1503.
4. Talley NJ, Vakil NB, Moayyedi P. American Gastroenterological Association technical review on the evaluation of dyspepsia. Gastroenterology 2005; 129: 1756-1780.
5. Lacy BE, Cash BD. A 32-year-old woman with chronic abdominal pain. JAMA 2008; 299: 555-565.
6. Lacy BE. Functional dyspepsia and gastroparesis: one disease or 2? Am J Gastroenterol 2012; 107: 1615-1620.
7. Camilleri M, Dubois D, Coulie B et al. Prevalence and socioeconomic impact of upper gastrointestinal disorders in the United States: results of the US Upper Gastrointestinal Study. Clin Gastroenterol Hepatol 2005; 3: 543-552.
8. El-Serag HB, Talley NJ. Systematic review: the prevalence and clinical course of functional dyspepsia. Aliment Pharmacol Ther 2004; 19: 643-654.
9. Castillo EJ, Camilleri M, Locke GR III et al. A community-based, controlled study of the epidemiology and pathophysiology of dyspepsia. Clin Gastroenterol Hepatol 2004; 2: 985-996.
10. Ford AC, Forman D, Bailey AG et al. Initial poor quality of life and new onset of dyspepsia: results from a longitudinal 10-year follow-up study. Gut 2007; 56: 321-327.
11. El-Serag HB, Talley NJ. Health-related quality of life in functional dyspepsia. Aliment Pharmacol Ther 2003; 18: 387-393.
12. Moayyedi P, Mason J. Clinical and economic consequences of dyspepsia in the community. Gut 2002; 50 (Suppl IV): iv10-iv12.
13. Brook RA, Kleinman NL, Choung RS et al. Functional dyspepsia impacts absenteeism and direct and indirect costs. Clin Gastroenterol Hepatol 2010; 8: 498-503.
14. Lacy BE, Weiser KT et al. Functional dyspepsia: the economic impact to patients. Aliment Pharmacol Ther 2013; 38: 170-177.
15. Tack J, Bisschops R, Sarnelli G. Pathophysiology and treatment of functional dyspepsia. Gastroenterology 2004; 127: 1239-1255.
16. Zigmond AS, Snaith RP. The Hospital Anxiety and Depression Survey. Acta Psychiatr Scand 1983; 67: 361-370.
17. Patton JH, Stanford MS, Barratt ES. Factor structure of the Barratt impulsiveness scale. J Clin Psychol 1995; 51: 768-774.
18. Littenberg B, Partilo S, Licata A, Kattan MW. Paper Standard Gamble: the reliability of a paper questionnaire to assess utility. Med Decis Making 2003; 23: 480-488.
19. Drossman DA, Morris CB, Schneck S et al. International survey of patients with IBS. Symptom features and their severity, health status treatments, and risk taking to achieve clinical benefit. J Clin Gastroenterol 2009; 43: 541-550.
20. Lacy BE, Everhart KK, Weiser KT et al. IBS patients' willingness to take risks with medications. Am J Gastroenterol 2012; 107: 804-809.
21. Damen NL, Pelle A, Szabo BM et al. Symptoms of anxiety and cardiac hospitalizations at 12 months in patients with heart failure. J Gen Intern Med 2012; 27: 345-350.
22. Lacy BE, Everhart K, Crowell MD. Functional dyspepsia is associated with sleep disorders. Clin Gastroenterol Hepatol 2011; 9: 410-414.
23. Francis CY, Morris J, Whorwell PJ. The irritable bowel severity scoring system: a simple method of monitoring irritable bowel syndrome and its progress. Aliment Pharmacol Ther 1997; 11: 395-402.